ID   Li-24
AC   CVCL_VN27
SY   Li24; C-Li24; C-Li-24
DR   Cosmic; 721065
DR   Wikidata; Q95982133
RX   PubMed=2542205;
RX   PubMed=7832798;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=2542205; DOI=10.1111/j.1349-7006.1989.tb02290.x; PMCID=PMC5917712;
RA   Tsuda, Hitoshi
RA   Hirohashi, Setsuo
RA   Shimosato, Yukio
RA   Ino, Yoshinori
RA   Yoshida, Teruhiko
RA   Terada, Masaaki
RT   "Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in
RT   human hepatocellular carcinoma.";
RL   Jpn. J. Cancer Res. 80:196-199(1989).
//
RX   PubMed=7832798; DOI=10.1006/bbrc.1995.1123;
RA   Kato, Nobuyuki
RA   Nakazawa, Takahide
RA   Mizutani, Tetsuya
RA   Shimotohno, Kunitada
RT   "Susceptibility of human T-lymphotropic virus type I infected cell
RT   line MT-2 to hepatitis C virus infection.";
RL   Biochem. Biophys. Res. Commun. 206:863-869(1995).
//